Human Insulin Receptor MAb-IDUA fusion protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Human Insulin Receptor MAb-IDUA fusion protein, covering 2023-03-15 to 2023-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I [Phase 1, Phase 2]